ISMD - ETF AI Analysis

Top Page

Inspire Small/Mid Cap Impact ETF (ISMD)

Rating:63Neutral

Price Target:―

The Inspire Small/Mid Cap Impact ETF (ISMD) has a moderate overall rating, reflecting a mix of strengths and challenges among its holdings. Strong contributors like Haemonetics (HAE) and Herbalife (HLF) stand out due to robust financial metrics and positive earnings call insights, though caution is warranted with overbought technical indicators. However, weaker holdings such as Xencor (XNCR) and NeoGenomics (NEO), which face significant profitability and valuation challenges, weigh on the fund's overall performance. A key risk factor is the ETF's exposure to companies with financial struggles, which could impact its stability.

Positive Factors

Strong Top Holdings Performance

Several top holdings, such as ViaSat and Eos Energy Enterprises, have delivered strong year-to-date gains, supporting the ETF's overall performance.

Sector Diversification

The ETF is spread across multiple sectors, including Industrials, Financials, and Technology, reducing reliance on any single industry.

Healthy Year-to-Date Performance

The ETF has shown positive year-to-date performance, indicating resilience in the current market environment.

Negative Factors

High Expense Ratio

The ETF charges a relatively high expense ratio compared to many passive funds, which can eat into investor returns over time.

Underperforming Holdings

Some top holdings, such as Tandem Diabetes Care and NeoGenomics, have experienced significant declines, which could weigh on future performance.

Over-Concentration in U.S. Market

The ETF has nearly 100% exposure to U.S. companies, limiting diversification and increasing vulnerability to domestic market risks.

ISMD vs. SPDR S&P 500 ETF (SPY)

AUM225.44M

RegionNorth America

Expense Ratio0.57%

Beta0.99

IssuerInspire

Inception DateFeb 28, 2017

Dividend Yield1.16%

Asset ClassEquity

Index TrackedInspire Small/Mid Cap Impact Equal Weight Index

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume18,585

30 Day Avg. Volume28,124

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

45.49

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering493

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

ISMD Summary

The Inspire Small/Mid Cap Impact ETF (ISMD) is an investment fund that focuses on small and mid-sized companies in the U.S., offering a chance to support businesses with high growth potential while aligning with ethical values. It follows the Inspire Small/Mid Cap Impact Equal Weight Index and invests in companies that meet strict moral and ethical standards, such as Plug Power and NeoGenomics. This ETF is ideal for investors looking to diversify their portfolios and support socially responsible businesses. However, it’s important to note that small and mid-cap stocks can be more volatile, meaning their prices may rise and fall more dramatically than larger companies.

How much will it cost me?The Inspire Small/Mid Cap Impact ETF (ISMD) has an expense ratio of 0.57%, which means you’ll pay $5.70 per year for every $1,000 invested. This is higher than average for ETFs because it is actively managed and focuses on ethical investing, which involves more research and selection processes. While the cost is higher, it reflects the fund's commitment to aligning investments with specific moral and ethical standards.

What would affect this ETF?The Inspire Small/Mid Cap Impact ETF (ISMD) could benefit from growth in innovative sectors like technology and health care, as well as increased interest in ethical investing. However, it may face challenges from economic slowdowns that disproportionately affect small and mid-cap companies, as well as potential regulatory changes impacting industries like energy and financials. Its focus on U.S.-based firms also makes it sensitive to domestic economic conditions and interest rate fluctuations.

ISMD Top 10 Holdings

The Inspire Small/Mid Cap Impact ETF (ISMD) is leaning heavily into the entrepreneurial spirit of U.S.-based small and mid-cap companies, with a notable focus on financials and industrials. Stocks like Castle Biosciences and Arcutis Biotherapeutics are rising stars, buoyed by strong technical momentum and promising strategic initiatives. However, lagging names like NeoGenomics and Fluence Energy are holding back performance due to profitability and valuation concerns. With its ethical investing framework and sector diversity, ISMD offers a unique blend of growth potential and values-driven investing, though some holdings may need time to find their footing.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
PUMP	Propetro Holding	0.38%	$858.69K	$1.01B	14.44%	60 Neutral
FLNC	Fluence Energy	0.37%	$828.55K	$3.65B	5.78%	46 Neutral
CSTL	Castle Biosciences	0.35%	$792.88K	$1.14B	27.10%	60 Neutral
TNDM	Tandem Diabetes Care	0.35%	$779.67K	$1.33B	-41.20%	60 Neutral
HAE	Haemonetics	0.34%	$766.53K	$3.78B	-5.04%	70 Outperform
ARQT	Arcutis Biotherapeutics	0.33%	$743.52K	$3.60B	139.85%	60 Neutral
NEO	NeoGenomics	0.32%	$718.54K	$1.56B	-32.27%	55 Neutral
FORM	Formfactor	0.31%	$694.88K	$4.34B	31.92%	68 Neutral
HLF	Herbalife	0.31%	$690.60K	$1.29B	59.62%	69 Neutral
NVRI	Enviri	0.30%	$669.15K	$1.48B	141.79%	55 Neutral

ISMD Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

38.15

Positive

100DMA

37.83

Positive

200DMA

36.01

Positive

Market Momentum

MACD

-0.02

Negative

RSI

55.39

Neutral

STOCH

88.23

Negative

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ISMD, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 37.44, equal to the 50-day MA of 38.15, and equal to the 200-day MA of 36.01, indicating a bullish trend. The MACD of -0.02 indicates Negative momentum. The RSI at 55.39 is Neutral, neither overbought nor oversold. The STOCH value of 88.23 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ISMD.

ISMD Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
ISMD	―	―	$225.44M	0.57%	―
RSMC	―	―	$723.79M	0.75%	―
MSSM	―	―	$683.00M	0.57%	―
SMOT	―	―	$357.78M	0.49%	―
NBSM	―	―	$192.96M	0.65%	―
SMIZ	―	―	$162.12M	0.56%	―

Performance Comparison

ISMD

Inspire Small/Mid Cap Impact ETF

38.24

-1.75

-4.38%

RSMC

Rockefeller U.S. Small-Mid Cap ETF

―

MSSM

Morgan Stanley Pathway Small-Mid Cap Equity ETF

―

SMOT

VanEck Morningstar SMID Moat ETF

―

NBSM

Neuberger Berman Small-Mid Cap ETF

―

SMIZ

Zacks Small/Mid Cap ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents